Japan's BioComo Pursues Novel Ligand Approach To Immuno-Oncology

Avoids 4-1BB/OX-40 Toxicity Issues

 
• By Ian Haydock
  
Dividing breast cancer cell
Ligand Approach Holds Potential In Cancer • Source: Shutterstock

More from Japan

More from Focus On Asia